Hepatitis B Virus Hbsag Surface Protein Antigen vs Levofloxacin

## Hepatitis B Virus Hbsag Surface Protein Antigen vs Levofloxacin: Overview

This comparison examines the pharmacological differences between **Hepatitis B Virus Hbsag Surface Protein Antigen** and **Levofloxacin**.

## Mechanism of Action

**Levofloxacin**: Fluoroquinolone antibiotic inhibiting bacterial DNA gyrase and topoisomerase IV.

## Pharmacokinetics

**Half-life**: Hepatitis B Virus Hbsag Surface Protein Antigen — N/A; Levofloxacin — 6-8 hours.

## Chemical Properties

**Molecular Formula**: Hepatitis B Virus Hbsag Surface Protein Antigen — N/A; Levofloxacin — C18H20FN3O4.

**Molecular Weight**: Hepatitis B Virus Hbsag Surface Protein Antigen — N/A; Levofloxacin — 361.3680 g/mol.

**Type**: Hepatitis B Virus Hbsag Surface Protein Antigen — Vaccine component; Levofloxacin — Small molecule.